Faculty of Philosophy, University of Oxford, Oxford, United Kingdom; Kleijnen Systematic Reviews Ltd., Escrick, York YO19 6FD, United Kingdom.
(Joint 1(st) author): Clinic of Orthodontics and Pediatric Dentistry, Center of Dental Medicine, University of Zurich, Zurich, Switzerland.
J Clin Epidemiol. 2022 Aug;148:160-169. doi: 10.1016/j.jclinepi.2022.04.017. Epub 2022 Apr 18.
To estimate the proportion of healthcare interventions tested within Cochrane Reviews that are effective according to high-quality evidence.
We selected a random sample of 2,428 (35%) of all Cochrane Reviews published between 1 January 2008 and 5 March 2021. We extracted data about interventions within these reviews that were compared with placebo, or no treatment, and whose outcome quality was rated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. We calculated the proportion of interventions whose benefits were based on high-quality evidence (defined as having high quality GRADE rating for at least one primary outcome, statistically significant positive results, and being judged by review authors as effective. We also calculated the proportion of interventions that suggested harm.
Of 1,567 eligible interventions, 87 (5.6%) had high-quality evidence supporting their benefits. Harms were measured for 577 (36.8%) interventions. There was statistically significant evidence for harm in 127 (8.1%) of these. Our dependence on the reliability of Cochrane author assessments (including their GRADE assessments) was the main potential limitation of our study.
More than 9 in 10 healthcare interventions studied within recent Cochrane Reviews are not supported by high-quality evidence, and harms are under-reported.
估计在 Cochrane 综述中测试的医疗干预措施中,根据高质量证据有效者所占的比例。
我们随机抽取了 2008 年 1 月 1 日至 2021 年 3 月 5 日期间发表的所有 Cochrane 综述的 2428 项(35%)进行抽样。我们提取了这些综述中与安慰剂或无治疗相比的干预措施的数据,并且其结局质量使用推荐评估、制定与评价(Grading of Recommendations Assessment, Development and Evaluation,GRADE)系统进行了评级。我们计算了基于高质量证据的干预措施的比例(定义为至少一个主要结局的 GRADE 评级为高质量、统计学上显著阳性结果,且综述作者判断为有效)。我们还计算了提示有危害的干预措施的比例。
在 1567 项合格的干预措施中,有 87 项(5.6%)具有支持其获益的高质量证据。577 项(36.8%)干预措施测量了危害。其中 127 项(8.1%)有统计学意义的危害证据。我们对 Cochrane 作者评估(包括其 GRADE 评估)的可靠性的依赖是本研究的主要潜在局限性。
在最近的 Cochrane 综述中研究的医疗干预措施中,超过 9/10 没有高质量证据支持,并且危害报告不足。